BACKGROUND: Long-term exposure to particulate matter <2.5 µm in diameter (PM2.5) and ozone has been associated with the development and progression of cardiovascular disease and, in the case of PM2.5, higher cardiovascular mortality. Whether exposure to PM2.5 and ozone is associated with patients' health status and quality of life is unknown. We used data from 2 prospective myocardial infarction (MI) registries to assess the relationship between long-term PM2.5 and ozone exposure with health status outcomes 1 year after an MI. METHODS AND RESULTS: TRIUMPH (Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction) and PREMIER (Prospective Registry Evaluating Myocardial Infarction: Events and Recovery) enrolled patients presenting with MI at 31 US hospitals between 2003 and 2008. One year later, patients were assessed with the disease-specific Seattle Angina Questionnaire, and 5-year mortality was assessed with the Centers for Disease Control's National Death Index. Individual patients' exposures to PM2.5 and ozone over the year after their MI were estimated from the Environment Protection Agency's Fused Air Quality Surface Using Downscaling tool that integrates monitoring station data and atmospheric models to predict daily air pollution exposure at the census tract level. We assessed the association of exposure to ozone and PM2.5 with 1-year health status and mortality over 5 years using regression models adjusting for age, sex, race, socioeconomic status, date of enrollment, and comorbidities. In completely adjusted models, higher PM2.5 and ozone exposure were independently associated with poorer Seattle Angina Questionnaire summary scores at 1-year (β estimate per +1 SD increase =-0.8 [95% CI, -1.4 to -0.3; P=0.002] for PM2.5 and -0.9 [95% CI, -1.3 to -0.4; P<0.001] for ozone). Moreover, higher PM2.5 exposure, but not ozone, was independently associated with greater mortality risk (hazard ratio =1.13 per +1 SD [95% CI, 1.07-1.20; P<0.001]). CONCLUSIONS: In our study, greater exposure to PM2.5 and ozone was associated with poorer 1-year health status following an MI, and PM2.5 was associated with increased risk of 5-year death.
BACKGROUND: Long-term exposure to particulate matter <2.5 µm in diameter (PM2.5) and ozone has been associated with the development and progression of cardiovascular disease and, in the case of PM2.5, higher cardiovascular mortality. Whether exposure to PM2.5 and ozone is associated with patients' health status and quality of life is unknown. We used data from 2 prospective myocardial infarction (MI) registries to assess the relationship between long-term PM2.5 and ozone exposure with health status outcomes 1 year after an MI. METHODS AND RESULTS: TRIUMPH (Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction) and PREMIER (Prospective Registry Evaluating Myocardial Infarction: Events and Recovery) enrolled patients presenting with MI at 31 US hospitals between 2003 and 2008. One year later, patients were assessed with the disease-specific Seattle Angina Questionnaire, and 5-year mortality was assessed with the Centers for Disease Control's National Death Index. Individual patients' exposures to PM2.5 and ozone over the year after their MI were estimated from the Environment Protection Agency's Fused Air Quality Surface Using Downscaling tool that integrates monitoring station data and atmospheric models to predict daily air pollution exposure at the census tract level. We assessed the association of exposure to ozone and PM2.5 with 1-year health status and mortality over 5 years using regression models adjusting for age, sex, race, socioeconomic status, date of enrollment, and comorbidities. In completely adjusted models, higher PM2.5 and ozone exposure were independently associated with poorer Seattle Angina Questionnaire summary scores at 1-year (β estimate per +1 SD increase =-0.8 [95% CI, -1.4 to -0.3; P=0.002] for PM2.5 and -0.9 [95% CI, -1.3 to -0.4; P<0.001] for ozone). Moreover, higher PM2.5 exposure, but not ozone, was independently associated with greater mortality risk (hazard ratio =1.13 per +1 SD [95% CI, 1.07-1.20; P<0.001]). CONCLUSIONS: In our study, greater exposure to PM2.5 and ozone was associated with poorer 1-year health status following an MI, and PM2.5 was associated with increased risk of 5-year death.
Entities:
Keywords:
comorbidities; myocardial infarction; ozone; particulate matter; quality of life
Authors: Michelle C Turner; Michael Jerrett; C Arden Pope; Daniel Krewski; Susan M Gapstur; W Ryan Diver; Bernardo S Beckerman; Julian D Marshall; Jason Su; Daniel L Crouse; Richard T Burnett Journal: Am J Respir Crit Care Med Date: 2016-05-15 Impact factor: 21.405
Authors: Desinia B Miller; Andrew J Ghio; Edward D Karoly; Lauren N Bell; Samantha J Snow; Michael C Madden; Joleen Soukup; Wayne E Cascio; M Ian Gilmour; Urmila P Kodavanti Journal: Am J Respir Crit Care Med Date: 2016-06-15 Impact factor: 21.405
Authors: Elisabeth Thiering; Iana Markevych; Irene Brüske; Elaine Fuertes; Jürgen Kratzsch; Dorothea Sugiri; Barbara Hoffmann; Andrea von Berg; Carl-Peter Bauer; Sibylle Koletzko; Dietrich Berdel; Joachim Heinrich Journal: Environ Health Perspect Date: 2016-02-05 Impact factor: 9.031
Authors: Dan L Crouse; Paul A Peters; Perry Hystad; Jeffrey R Brook; Aaron van Donkelaar; Randall V Martin; Paul J Villeneuve; Michael Jerrett; Mark S Goldberg; C Arden Pope; Michael Brauer; Robert D Brook; Alain Robichaud; Richard Menard; Richard T Burnett Journal: Environ Health Perspect Date: 2015-11-01 Impact factor: 9.031
Authors: Jonathan D Newman; Deepak L Bhatt; Sanjay Rajagopalan; John R Balmes; Michael Brauer; Patrick N Breysse; Alison G M Brown; Mercedes R Carnethon; Wayne E Cascio; Gwen W Collman; Lawrence J Fine; Nadia N Hansel; Adrian Hernandez; Judith S Hochman; Michael Jerrett; Bonnie R Joubert; Joel D Kaufman; Ali O Malik; George A Mensah; David E Newby; Jennifer L Peel; Jeffrey Siegel; David Siscovick; Betsy L Thompson; Junfeng Zhang; Robert D Brook Journal: J Am Coll Cardiol Date: 2020-12-15 Impact factor: 24.094
Authors: Claire L Leiser; Ken R Smith; James A VanDerslice; Jason P Glotzbach; Timothy W Farrell; Heidi A Hanson Journal: J Clin Med Date: 2019-12-02 Impact factor: 4.241